Status:
TERMINATED
Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial
Lead Sponsor:
Walter Reed National Military Medical Center
Conditions:
Pseudofolliculitis Barbae
Eligibility:
All Genders
18-64 years
Phase:
PHASE4
Brief Summary
To study the efficacy of topical eflornithine for pseudofolliculitis barbae from a quality of life standpoint and with objective physician-measured lesion counts. Our hypothesis is that the hair growt...
Detailed Description
Pseudofolliculitis barbae (PFB), or 'ingrown hairs,' is a common skin disease of the face and neck caused by shaving in predisposed individuals who have naturally curly hair. It affects a disproportio...
Eligibility Criteria
Inclusion
- Active Duty Service Members with Pseudofolliculitis Barbae
Exclusion
- Previous treatment with laser hair removal in the previous 12 months, Currently pregnant, seeking pregnancy, or breast feeding
Key Trial Info
Start Date :
September 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2023
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04403282
Start Date
September 27 2020
End Date
June 22 2023
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20814